Shrewsbury, MA, United States of America

Nigel S Moore


Average Co-Inventor Count = 27.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):

Certainly! Here is an article about inventor Nigel S Moore:

Title: Innovator Spotlight: Nigel S Moore - Pioneering Kinase Inhibitors

Introduction:

Nigel S Moore is a renowned inventor based in Shrewsbury, MA (US) known for his groundbreaking work in the field of pharmaceuticals. With a keen focus on developing compounds to inhibit kinases, Moore has made significant contributions to the medical community.

Latest Patents:

Moore holds a key patent titled "5-substituted indazoles as kinase inhibitors". This patent revolves around compounds that play a crucial role in inhibiting various kinases such as Glycogen Synthase kinase 3 (GSK-3), Rho kinase (ROCK), Janus Kinases (JAK), and many more. These compounds have shown promising results in the realm of kinase inhibition.

Career Highlights:

Currently affiliated with AbbVie Inc., Moore brings a wealth of experience and expertise to the company's research and development department. His tireless dedication to innovation has led to the successful development of novel pharmaceutical compounds with the potential to revolutionize the treatment of various diseases.

Collaborations:

In his professional journey, Moore has had the privilege of collaborating with esteemed colleagues such as Irini Akritopoulou-Zanze and Brian D Wakefield. Together, they have worked tirelessly to push the boundaries of pharmaceutical research and develop groundbreaking solutions for complex medical challenges.

Conclusion:

In conclusion, Nigel S Moore stands as a visionary inventor in the field of pharmaceuticals, with a strong focus on kinase inhibitors. His relentless pursuit of innovation and collaboration with industry experts underscores his commitment to driving positive change in the medical landscape. Moore's contributions continue to inspire and pave the way for future advancements in pharmaceutical research and development.

If you need further information or have any other requests, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…